biomarkers

The autism-associated 16p11.2 microdeletion variant impacts the effects of microbiota disturbances on hippocampal development and behavior throughout the lifespan

Approximately 17% of children are diagnosed with NDDs, including ASD, ADHD, and ID, which are highly heterogenous, frequently co-occur, and manifest in early life in sex-dependent fashion. We speculate that

The autism-associated 16p11.2 microdeletion variant impacts the effects of microbiota disturbances on hippocampal development and behavior throughout the lifespan2026-06-05T10:02:48-05:00

Improving Clinical Understanding of Autism

The need for biomarkers in autism McPartland describes how autism is diagnosed, highlighting that these methods have remained largely unchanged since the initial descriptions in 1943 (5:00). Although today we understand

Improving Clinical Understanding of Autism2026-08-28T13:24:17-05:00

Biomarkers start telling us a story: Autism pathophysiology revisited

The complexity of autism pathophysiology Persico considers classic approaches to biomarker research and how they inform diagnosis, risk assessments, and developmental trajectories for neurodevelopmental conditions (8:10). However, focusing on biomarkers

Biomarkers start telling us a story: Autism pathophysiology revisited2026-08-25T16:36:47-05:00
Go to Top